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Abstract
Purpose: The scientific experiments with new immu-
nological methods (immunoblotting, RAST inhibition) and 
isolation of recombinant allergens suggest structural simi-
larities in the allergenic components responsible for cross-
reactions. Immunochemical and molecular biology studies 
indicate that epitopes of major allergen (Bet v 1, Mal  d 1) 
contain more IgE binding epitopes than minor allergens 
(Bet v 2, Mal d 2), what explained clinical importance of 
major birch and apple allergens, but it is individual. The 
important role in cross-reactivity play also proteins with 
low molecular weight; a potentially dangerous allergen is 
lipid transfer protein (LTP) inducing severe systemic reac-
tions in allergic subjects. The recent studies indicate that 
the IgE cross-reactivity patterns and the clinical relevance is 
still not clear and that only some of patients with confirmed 
IgE cross allergy to Bet v 1 and Mal d 1 demonstrated clini-
cal symptoms after ingesting of apple. The aim of study was 
to establish the pattern of cross-reactivity between major 
(Bet  v 1) and minor (Bet v 2) birch pollen allergens and 
apple proteins in children allergic to birch using recom-
binant allergens and immunoblotting method. 
Material and methods: The prospective study were car-
ried out on the group of 13 children aged 4-16 years, referred 
to the IIIrd Department of Paediatrics in Białystok and out-
patient clinic with clinical symptoms of food and inhalant 
allergy. Inclusion criteria to the study were: allergy to birch 
pollen recombinant allergens and apple, confirmed by pres-
ence of specific IgE in the sera of patients. The allergens 
from peel and pulp of apple and birch were separated and 
loaded onto the polyacrylamide electrophoretic gel and than 
transferred to membranes by western blotting. Antigen-IgE 
complex was detected using goat anti-human IgE antibodies 
labelled with alkaline phosphatase.
Results: Only few sera presented strong reactions in 
immunoblotting to birch pollen proteins with a molecular 
weight of 17-18 kDa, corresponding to the main birch aller-
gen Bet v 1. Most of sera having positive reaction vs Bet v  1 
showed cross-reactivity with Mal d 1. All sera recognized 
specifically the main allergen of apple peal Mal d 3 with 
molecular weight <10 kDa (Lipid Transfer Protein).
Conclusions: Immunoblotting method allows to verifica-
tion of cross-reactivity recognized by presence of specific 
IgE. The nature of proteins responsible for sensitization can 
influence the spectrum of offending foods and the clinical 
features of allergic reactions.
Key words:  cross-reactivity, birch-apple syndrome, 
immunoblotting, recombinant allergens, lipid 
transfer protein.
Abbreviations:  IgE – immunoglobulin E; LTP – lipid 
transfer protein; RAST inhibition – radioallergosorbent test 
inhibition; SDS-PAGE – sodium dodecyl sulfate polyacrylamide 
gel electrophoresis.
Introduction
Patients allergic to birch pollen often also react with fruit 
and vegetables, such as apple and cross-reactivity of allergen-
specific antibodies is a well-known phenomenon in food allergy 
[1,2]. Allergies to plant foods are based on cross-reactive IgE 
and adverse food reactions are mainly due to a specific family 
of related proteins. All these proteins seem to possess structural 
similarities. Proteins that share common epitopes with Bet v 1, 
268 Cudowska B, et al. 269Immunoblotting in the diagnosis of cross-reactivity in children allergic to birch
the major birch pollen allergen, occur in other kinds of tree pol-
len, apples, stone fruit, celery, carrots and nuts [2]. The major 
cause of cross-reactivity between birch and apple is biochemi-
cal and immunological similarity between the major allergens, 
Bet  v  1 and Mal d 1 [1]. Isolation and sequencing of the major 
allergen Mal d 1 from apple have shown a high degree of sequen-
tial homology with Bet v 1 and it has been demonstrated that 
Mal d 1 and Bet v 1 cross-react at T-cell level [3]. Bet v 1 belongs 
to class 10 of pathogenesis-related proteins. Other major aller-
gen from apple (Mal d 2) has been identified as thaumatin-like 
proteins. In contrast to Bet v 1, two minor allergenic structures 
which sensitize about 10-20% of all pollen-allergic patients, are 
named profilins and cross-reactive carbohydrate determinants 
[2]. Cross-reactivity between birch pollen and apple has been 
demonstrated using allergen extracts in RAST inhibition, as well 
as immunoblotting [1]. A common observation of cross-reactivi-
ties has shown that a relatively high number of these seem to be 
without clinical significance [4]. More recently, a lipid transfer 
protein has been reported to be an important allergen in apple 
(Mal d 3). Lipid transfer protein (LTP), the major allergen in 
Rosaceae fruit in areas where the prevalence of birch pollen 
allergy is low, is a potentially dangerous allergen. Because of its 
extreme resistance to pepsin digestion, LTP probably reaches 
the intestinal tract in an almost unmodified form inducing 
severe systemic reactions in allergic subjects. In fact, lipid 
transfer proteins from apple showed a homology higher than 
90%, which clearly explains immunochemical cross-reactivity in 
patients not allergic to birch pollen [5].
Food proteins and profilins of the Bet v 1 family are rela-
tively sensitive to heat and can be easily cleaved by proteases. 
Serological assays and skin prick tests allow no distinction 
between symptomatic and asymptomatic patients. Positive 
serological assays should not be taken as indicators for a strict 
avoidance of foods which are tolerated [2].
Despite the increasing knowledge of cross-reactive struc-
tures and the role of recombinant allergens, it is still not clear 
the IgE cross-reactivity patterns and the clinical relevance [2,4]. 
According to the published data, sensitization to Bet v 1 or pro-
filin is not always associated with IgE against specific foods. The 
correlation has been found between Bet v 1 and apple, peach, 
hazelnut in patients allergic to birch, but the actual question is, if 
patients allergic to apple demonstrate reactivity to Bet v 1 [2,6]. 
The aim of our study was to determine the pattern of cross-
reactivity between birch pollen and apple in children allergic to 
birch using recombinant allergens and immunoblotting method. 
The correlation between immunochemical cross-reactivity to 
apple and birch was also established.
Material and methods
Patients
The prospective study were carried out on the group of 13 
children aged 4-16 years, referred to the IIIrd Department of 
Paediatrics in Białystok and outpatient clinic with clinical symp-
toms of food and inhalant allergy. Inclusion criteria to the study 
were: allergy to birch pollen recombinant allergens (Bet v 1
 and Bet v  2) and apple, confirmed by estimation of specific 
IgE in the sera of patients. Exclusion criteria were: chronic 
diseases of respiratory and digestive tract with different than 
allergic background, parasites infections, autoimmunological 
disorders.
Determination of total IgE and specific IgE antibodies
Serum samples (2 ml) were analyzed for concentration 
of total IgE and specific IgE antibodies to birch recombinant 
(Bet  v 1 and Bet v 2) and apple allergens (Pharmacia Upjohn) 
with a fluoroimmunoenzymatic essay (UniCAP) according to 
the manufacture’s instruction. The detection limit of the CAP 
system is 0.35 kU/L IgE; measurable specific IgE was defined 
as a positive test result if >0.7 kU/L. The results of total and 
specific IgE to birch and apple are presented in Tab. 1.
Immunoblotting
Immunoblotting has been performed in the cooperation 
with the Department of Pharmacology in the University of 
Milan in Italy with the procedures described bellow.
Apple
The apples were purchased from a greengrocer of Milan; 
they belonged to three varieties: Golden Delicious, Stark Deli-
cious and Smith. Peel and pulp were separated, freeze-dried and 
suspended in Sample buffer:water (1:1, v:v) at the final concen-
tration of 150 mg/mL. After a night at room temperature, sam-
ples were centrifuged at 10 000 rpm and 4°C for 20 minutes. The 
supernatant was collected and loaded onto the electrophoretic 
gel. Sample buffer contained 0.25M TRIS-HCl pH 6.8, 7.5% 
glycerol, 2% SDS, 5% -mercaptoethanol.
Birch 
A birch solution for prick test (STALLERGENES SA) was 
diluted 1:1 (v:v) with Sample buffer and loaded onto a gel.
Table 1. Total and specific IgE in the investigated patients 
(N=13)
No Initials
Age
 (yrs)
IgE
(IU/ml)
Specific IgE to birch 
allergens
(class)
Specific 
IgE
to apple 
(class)Birch Bet v 1 Bet v 2
1. M.W. 14 65 3 3 0 2
2. K.K. 4 >5000 3 3 3 2
3. J.M. 12 3293 4 4 3 2
4. M.R. 8 >5000 2 0 0 3
5. J.Z. 2 2077 5 5 0 3
6. P.L. 12 356 2 0 0 2
7. J.B. 13 965 3 3 0 2
8. M.W. 13 110 4 4 0 1
9. J.S. 14 211 3 3 2 2
10. L.M. 9 1081 3 3 0 4
11. M.K. 4 141 6 6 0 4
12. K.K. 13 792 4 4 0 3
13. E.P. 16 >1000 3 2 0 2
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A
D
kDa
C
B
194.7
116.4
95.1
51.2
36.6
28.9
19.9
6.5
STPP STPL GDPP GDPL SMPP SMPL MK BP
Sodium Dodecyl Sulfate Polyacrylamide Gel Electro-
phoresis (SDS-PAGE)
Apple and birch proteins were separated on a gradient 
polyacrylamide gel with the following characteristics:
1 – Gradient running gel: 12-22% acrylamide; 0.11-0.20% 
bis-acrylamide; 0.36 M TRIS-HCl buffer pH 8.8; 35% glycerol; 
0.1% SDS; 0.02% ammonium persulfate; and 0.15% N,N,N’,N’-
tetramethylenediamine (TEMED).
2 – Stacking gel: 3.5% acrylamide; 0.09% bis-acrylamide; 
0.125 M TRIS-HCl buffer pH 6.8; 0.1% SDS; 0.02% ammonium 
persulfate; and 0.15% (TEMED).
3 – Running buffer: 25 mM TRIS, 0.19M glycine and 0.1% 
SDS (w/v), pH 8.8.
After the electrophoretic run (90 V at room temperature, 
for approximately 6 h) gels were dyed with Coomassie Brilliant 
Blue G-250. All materials and instruments were purchased from 
Bio-Rad (Richmond CA, USA). 
Molecular Weight Marker Solution (prestained broad 
range, Bio-Rad) contained myosin (rabbit muscle; 194.7 kDa),
-galactosidase (Escherichia coli; 116.4 kDa), bovine serum 
albumin (95.1 kDa), ovalbumin (chicken egg; 51.2 kDa), 
carbonic anhydrase (bovine erythrocytes; 36.6 kDa), soybean 
trypsin inhibitor (soybean; 28.9 kDa), lysozyme (chicken egg 
white; 19.9 kDa) and aprotinine (bovine pancreas; 6.5 kDa). 
Immunoblotting
After SDS-PAGE, proteins were transferred to polyvinyli-
dene difluoride (PVDF) membrane (PVDF; Immobilon P, Mil-
lipore, Bedford, MA, USA) by western blotting in a Trans-blot 
Electrophoretic Transfer Cell (Bio-Rad). The transfer buffer 
was 25 mM Tris, 193 mM glycine and 20% methanol. The mem-
branes were blocked with 1% gelatin and washed three times 
with 0.25% gelatin solution (in 150 mM NaCl, 5 mM EDTA, 
50 mM Tris, 0.05% Triton-X) to prevent non-specific adsorp-
tion of the immunological reagents. The membrane was then 
immersed in 10 mL of 0.25% gelatin solution containing 0.5 ml 
of serum from allergic children. Antigen-IgE complex was 
detected using goat anti-human IgE antibodies (Sigma Aldrich, 
Milan, Italy) labelled with alkaline phosphatase; the secondary 
antibody commercial stock was diluted 1/1000 (v:v) in 0.25% 
gelatin solution. After incubation for 4 h at room temperature 
with shaking, membranes were washed twice with 0.25% (2 min 
each) and once with Tris buffer solution (20 mM Tris and 0.5 M 
NaCl) for 5 min.
Finally, after incubation in bromochloroindolyl phosphate-
nitroblue tetrazolium (BCIP-NBT) solution, an intense black-
purple precipitate developed at the site of enzyme binding. 
The developing solution contained 15% BCIP and 30% NBT 
in alkaline phosphatase buffer (100 mM Tris, 100 mM NaCl, 
5  mM MgCl2, pH 9.5).  
Results
The electrophoretic pattern of apple pulp and peel belong-
ing to the three selected varieties (Malus domestica var. golden 
delicious, stark delicious and smith) are shown in SDS-PAGE 
(Fig. 1). In parallel, the profile of pollen birch proteins is shown. 
The protein profile of apple samples is not well defined; in fact, 
several proteins are distributed in the range of molecular weights 
6.5-95.1 kDa. Same proteins are well defined and among them 
the most abundant component (both in pulp and peel samples) 
presents a molecular weight of approximately 17-18 kDa.  
The profile of birch pollen presents three major proteins, 
having molecular weights of approximately 18, 31, 35.5 kDa. 
Circulating IgEs from the 13 sera included in this study were 
tested for reactivity against apple peel and pulp, and birch pol-
len allergens. The use of prestained Molecular Weight standard 
solution (broad range) allowed the identification of the proteins 
recognized by circulating IgEs (positive reaction in immunoblot-
ting).
The main results can be summarized as follows:
1. Reactivity to birch pollen
Only sera of 4 patients presented strong reaction to birch 
pollen proteins (Fig. 2). The protein recognized by these sera 
Figure 2. Reactivity vs birch pollen proteins 17-18 kDa in one of 
patient allergic to birch (membrane incubated with serum 11)
St – Malus domestica var. stark delicious; PP – pulp; Gd – Malus 
domestica var. Golden Delicious; PL – peel; Sm – Malus domestica 
var. Smith; MK – molecular weight marker solution; BP – birch 
pollen
Figure 1. SDS-PAGE of apple peel and pulp and birch pollen
St – Malus domestica var. stark delicious; PP – pulp; Gd – Malus 
domestica var. Golden Delicious; PL – peel; Sm – Malus domestica 
var. Smith; MK – molecular weight marker solution; BP – birch 
pollen
Molecular weight:
A: 18.4 kDa; B: 17.7 kDa; C: 31 kDa; D: 35.4 kDa
17.7 kDa
kDa
194.7
116.4
95.1
51.2
36.6
28.9
19.9
6.5
STPP STPL GDPP GDPL SMPP SMPL MK BP
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Figure 4. Reactivity vs major component of apple peel (Mal d 3 
– Lipid Transfer Protein) (membrane incubated with serum 1)
St – Malus domestica var. stark delicious; PP – pulp; Gd – Malus 
domestica var. Golden Delicious; PL – peel; Sm – Malus domestica 
var. Smith; MK – molecular weight marker solution; BP – birch 
pollen
presented a molecular weight of approximately 17-18 kDa, cor-
responding to the main birch allergen Bet v 1. IgEs from the 
child 5 recognized in the birch pollen sample: a protein having 
molecular weight of 17-18 kDa (Bet v 1), and two bands of 
approximately 30 kDa  (Bet v 6) (Fig. 3). Since allergy to birch 
pollen was the inclusion criterium for this study we must con-
clude that birch allergens contain conformational epitopes that 
loose their reactivity after denaturating processes (treatment 
with SDS and -mercaptoethanol). Probably, only the sera from 
the most reactive subjects are capable to recognize denatured 
birch allergens.
2. Reactivity to apple peel proteins
All subjects presented reactivity against the major compo-
nent of peel. Considering its molecular weight (<10 kDa), this 
protein can be identified as the known allergen Lipid Transfer 
Protein (Mal d 3) (Fig. 4). The reactivity against pulp proteins is 
characterized by a complex pattern of responses:
Serum 1: no reactivity
Serum 2: no significant reactivity
Serum 3: no significant reactivity
Serum 4: some reactivity to the peel allergen Mal d 1 (MW 
17-18 kDa)
Serum 5: reactivity versus two allergens having molecular 
weights of app. 30 kDa
Serum 6: weak reactivity versus the allergen having molecu-
lar weight of 17-18 kDa (Mal d 1). The reaction is 
stronger versus apple Golden
Serum 7: reactivity versus the allergen having molecular 
weight of 17-18 kDa (Mal d 1). The reaction is stronger 
versus apple Golden
Serum 8: no reactivity
Serum 9: reactivity versus the allergen having molecular 
weight of 17-18 kDa (mainly in apple Golden) corre-
sponding to the major birch pollen allergen (Bet v 1)
Serum 10: no significant reactivity
Serum 11: low reactivity versus the allergen Mal d 1 
Serum 12: strong reaction versus Mad d 1 in the sample 
containing the apple var Smith (Fig. 5)
Serum 13: no significant reactivity.
Discussion
Cross-reactivity between birch pollen and apple has been 
confirmed by analysis of recombinant proteins and using RAST 
inhibition and immunoblotting. The major cause of birch-apple 
syndrome is biochemical and immunological similarity between 
major allergens, Bet v 1 and Mal d 1 [1]. The epitopes of major 
allergens (Bet v 1, Mal d 1) show the highest IgE-affinity, but 
the different patterns of IgE-binding were also observed in 
individuals. Approximately 70% of patients who are allergic 
to birch pollen may experience symptoms after consumption of 
apple and fruit from family Rosaceae. Most of patients suffer 
from local symptoms at the site of the primary allergen contact 
(oral allergy syndrome) [2]. Some of them are also sensitized to 
minor birch pollen allergen; profilin Bet v 2, but recent studies 
suggested that profilin sensitization has little or not clinical 
relevance [2,7,8]. A  possible reason for this fact is monosen-
sitization to profilin or sensitization to other cross-reacting 
Figure 5. Strong reactivity vs Mal d 1 in the sample containing 
the apple var. Smith (incubation with serum 12)
St – Malus domestica var. stark delicious; PP – pulp; Gd – Malus 
domestica var. Golden Delicious; PL – peel; Sm – Malus domestica 
var. Smith; MK – molecular weight marker solution; BP – birch 
pollen
Figure 3. Reactivity vs the allergens having molecular weight 
17-18 kDa and two bands of approximately 30 kDa (membrane 
incubated with serum 5)
St – Malus domestica var. stark delicious; PP – pulp; Gd – Malus 
domestica var. Golden Delicious; PL – peel; Sm – Malus domestica 
var. Smith; MK – molecular weight marker solution; BP – birch 
pollen
17.7 kDa
kDa
194.7
116.4
95.1
51.2
36.6
28.9
19.9
6.5
STPP STPL GDPP GDPL SMPP SMPL MK BP
<10 kDa
kDa
194.7
116.4
95.1
51.2
36.6
28.9
19.9
6.5
STPP STPL GDPP GDPL SMPP SMPL MK BP
kDa
194.7
116.4
95.1
51.2
36.6
28.9
19.9
6.5
STPP STPL GDPP GDPL SMPP SMPL MK BP
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structures in pollen and vegetables foods or to primary food 
allergens, such as LTP [2]. The recent studies indicated also that 
only 75% of patients with confirmed IgE cross-allergy Bet v 1 
– Mal d 1, demonstrate clinical symptoms after ingesting of 
apple. This homology between allergens is clinically irrelevant 
because of cross-reactive carbohydrate determinants [9]. In our 
group of children, we observed positive oral food challenge to 
apple in seven of them; 4 sera showed reactivity to Mal d 1 and 
all to Mal d 3.
The next problem is that the presence of specific IgE to 
birch and apple in the sera of patients can not be considered 
as the predicting factor of clinical symptoms. As was previ-
ously described, sensitization to Bet v 1 is specific for birch and 
apple allergies, whereas sensitization to Bet v 2 is common in 
polysensitized patients. In the investigations carried out by Rossi 
et al., more than half of patients with a history of oral allergy 
syndrome after eating apple reacted to Bet v 1 [10]. In our 
study only few among 13 children allergic to birch presented in 
immunoblotting specific IgE capable to recognize birch pollen 
allergens; probably due to the denaturating processes used in 
this technique. The protein of birch recognized by the sera of 4 
patients has a molecular weight corresponding to the main birch 
allergen Bet v 1 (17-18 kDa). As we have shown in the Tab. 1, all 
patients were allergic to birch according to the results of specific 
IgE. These results indicated that there is no correlation between 
these methods and that the presence of specific antibodies 
has not the clinical relevance. The great importance has also 
technical conditions of method. We supposed the influence of 
denaturating processes on the epitopes structure and the data 
obtained by other authors, concerning food allergens, confirmed 
these conclusions. The investigations carried out by Vieths and 
al. indicated that the proteins in the prick test solution appeared 
to be strongly degraded and that extraction procedures should 
be adapted to the specific source material [11].
Our results demonstrated that most of sera having positive 
reaction vs Bet v 1 showed cross-reactivity with Mal d 1, but 
some of patients showed reactivity to Mal d 1, even though 
the reactivity to birch was weak or absent. Detailed analysis 
of molecular surface areas performed by Holm et al. identifies 
potential epitopes for cross-reactive antibodies. A minimum of 
two epitopes would be necessary for cross-linking of receptor 
bound IgE in histamine release and skin test. The occurrence of 
limited epitope coincidence between Bet v 1 and Mal d 1 is in 
agreement with the observation that not all birch pollen allergic 
patients react with apple and that conformation of epitopes 
recognized by the IgE of the individual patients determines the 
degree of cross-reactivity [1]. 
Very interesting seem to be the results of reactivity to the 
apple protein with molecular weight <10 kDa, Mal d 3 (Lipid 
Transfer Protein). Our results showed that all sera, even these 
without reactivity in immunoblotting to birch, recognize specifi-
cally the main allergen of apple peel. LTP is the major allergen 
in Rosaceae fruit in areas where the prevalence of birch pollen 
allergy is low and is responsible for severe allergic reactions 
[5]. This protein show extreme heat stability and the results of 
investigations performed by Asero et al. suggest that LTP-hyper-
sensitive patients with a history of severe reactions induced by 
apple should be advised to avoid unpeeled apple even after it 
undergone thermal processing [5]. Clinical observation of the 
investigated group of children indicated that only some of chil-
dren demonstrated symptoms after ingestion of apple, but we 
didn’t notice severe clinical reactions among them. The results 
of our investigations and the prevalence of sensitization to LTP 
is the indication for considering the spectrum of offending foods 
and dietetic restrictions, because of the risk of potentially life-
threatening reactions relevant to heat stable and pepsin resist-
ant proteins [12]. 
The recently studies indicated that the expression of Mal d 1 
varies between different apple strains. Golden Delicious and 
Granny Smith apples have a high expression of Mal d 1 com-
pared to Jamba and Gloster. It is with correlation of clinical 
symptoms occurred more often after ingestion of green apples 
than red ones. Hansen and al. described the seasonal variation 
in food allergy to apple. Although specific IgE against Golden 
delicious increased during season, neither skin test nor immuno-
blotting could confirm an increase in reactivity. The results 
of immunoblotting performed with the sera of our patients, 
showed stronger reactions vs apple Golden. 
The analysis of the immunoblotting results in correlation to 
clinical observations of investigated children generally agreed 
that the diagnosis of food allergy must rely on the outcome of 
oral food challenge [13]. Because clinical aspect of cross reac-
tivity was not the subject of this paper, we didn’t compare the 
diagnostic accuracy of immunoblotting with clinical symptoms. 
But according to our experiences, we can suggest that immuno-
blotting is useful to verification of  cross-reactivity recognized by 
the presence of specific IgE.
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